• Jain G, Das P, Ranjan P, Neha, Valderrama F, Cieza-Borrella C. (2023) Urinary extracellular vesicles miRNA -A new era of prostate cancer biomarkers. Front. Genet. 14:1065757. doi: 10.3389/fgene.2023.1065757.
  • Bourke S, Urbano L, Midson MM, Olona A, Qazy-Choudhry, Panamarova M, Valderrama F, Long NJ, Dailey LA, Green M. (2022) Nearly monodispersed, emission-tuneable conjugated polymer nanoparticles. Sens. Diagn. 1, 1185-1188. https://doi.org/10.1039/D2SD00164K.
  • Llorente H, Perez-Rivera JA, Santos MA, Cieza-Borrella C, Pastor I, Novo-Veleiro I, Fernández-Mateos J, Chamorro AJ, Crecente-Otero P, Laso FJ, González-Sarmiento R, Marcos M. (2022) Genetic susceptibility to telomere shortening through the rs2293607 polymorphism is associated with a greater risk of alcohol use disorder. Mech Ageing Dev. 206:111693. doi: 10.1016/j.mad.2022.111693. 
  • Morrison AL, Campagna A, Bodman-Smith M. (2022). Sometimes simple is not best: The complex γδ T cell interaction with tumour needs depth. Clin. Transl. Disc. 2:e71. doi: 10.1002/ctd2.71.
  • Anton I, Calle Y, Ivetic A, Parsons M, Valderrama F, Wells C. (2021). Invad_2019-Mechano-chemical signals in invasion. Eur J Cell Biol. 100(4):151162. doi: 10.1016/j.ejcb.2021.151162.
  • Arisan ED, Rencuzogullari O, Cieza-Borrella C, Miralles Arenas F, Dwek M, Lange S, Uysal-Onganer P. (2021). MiR-21 Is Required for the Epithelial-Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells. Int J Mol Sci. 22(4):1557. doi: 10.3390/ijms22041557.
  • Haldrup J, Strand SH, Cieza-Borrella C, Jakobsson ME, Maibritt Norgaard MR, Hedensted S, Dagnaes-Hansen F, Parm Ulhoi B, Eeles R, Borre M, Olsen JV, Thomsen M, Kote-Jarai Z, Sorensen KD. (2021). FRMD6 has tumor suppressor functions in prostate cancer. Oncogene. 40(4):763-776. doi: 10.1038/s41388-020-01548-w.
  • Ahmed M, Goh C, Saunders E, Cieza-Borrella C; PRACTICAL consortium, Kote-Jarai Z, Schumacher FR, Eeles R. (2020). Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT. Prostate Cancer Prostatic Dis. 23(2):333-342. doi: 10.1038/s41391-019-0181-y.
  • Lopez-Valverde N, Lopez-Valverde A, Gomez-de-Diego R, Cieza-Borrella C, Ramirez JM, Gonzalez-Sarmiento R. (2019). Genetic Study in Patients Operated Dentally and Anesthetized With Articaine-Epinephrine. J Pain Res. 29;12:1371-1384. doi: 10.2147/JPR.S193745.
  • Leongamornlert DA, Saunders EJ, Wakerell S, Whitmore I, Dadaev T, Cieza-Borrella C, Benafif S, Brook MN, Donovan J, Hamdy F, Neal D, Muir K, Govindasami K, Conti DV, Kote-Jarai Z, Eeles RA. (2019). Germline DNA repair gene mutations in young onset prostate cancer cases in the UK: evidence for a more extensive genetic panel. Eur Urol. 76(3):329-337. doi: 10.1016/j.eururo.2019.01.050.
  • Mijuskovic M, Saunders EJ, Leongamornlert DA, Wakerell S, Whitmore I, Dadaev T, Cieza-Borrella C, Govindasami K, Brook MN, Haiman CA, Conti DV, Eeles RA, Kote-Jarai Z. (2019) Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease. Br J Cancer. 119(1):96-104. doi: 10.1038/s41416-018-0141-7.
  • Dadaev T, Saunders EJ, Newcombe P, Anokian E, Leongamornlert D, Brook MN, Cieza-Borrella C, Mijuskovic M, Stephens S, Al Olama AA, et al. (2018). Fine-mapping of Prostate Cancer Susceptibility Loci in a Large Meta-Analysis Identifies Candidate Causal Variants. Nat Commun. 11;9(1):2256. doi: 10.1038/s41467-018-04109-8.
  • Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, et al. (2018). Prostate cancer meta-analysis of more than 140,000 men identifies 63 novel prostate cancer susceptibility loci. Nat Genet. 50(7):928-936. doi: 10.1038/s41588-018-0142-8.
  • Novo-Veleiro I, Cieza-Borrella C, Pastor I, González-Sarmiento R, Laso FJ, Marcos M. (2018). Analysis of the relationship between interleukin polymorphisms within miRNA-binding regions and alcoholic liver disease. Rev Clin Esp. 218(4):170-176. doi: 10.1016/j.rce.2018.02.005.